AJP - Endocrinology and Metabolism, Vol 267, Issue 3 E369-E379, Copyright © 1994 by American Physiological Society

ARTICLES

Insulin's effect on protein kinase C and diacylglycerol induced by diabetes and glucose in vascular tissues

T. Inoguchi, P. Xia, M. Kunisaki, S. Higashi, E. P. Feener and G. L. King
Department of Medicine, Joslin Diabetes Center, Brigham and Women's Hospital, Boston, Massachusetts 02215.

We have reported that membranous protein kinase C (PKC) activities and total diacylglycerol (DAG) levels are increased in the heart and aorta of diabetic rats, which cannot be easily reversed by euglycemic control. However, insulin treatment, which achieved euglycemia, can prevent the increase in PKC activities and DAG levels. Chronic exposure to elevated glucose levels (5.5 vs. 22 mM) increased DAG levels in cultured bovine and rat aortic endothelial cells and smooth muscle cells by 31, 140, and 143%, respectively, only after 3 days of incubation. Glyceraldehyde, which can stimulate the de novo synthesis of DAG, significantly increased DAG levels by 7.1 +/- 0.6-fold after only 16 h of incubation. Elevated glucose levels did not affect labeled DAG when all of the vascular cells were incubated with [3H]arachidonate, [3H]glycerol, or [3H]phosphatidylcholine, whereas [3H]palmitate- and [3H]oleic acid-labeled DAG levels were significantly increased, indicating that the glucose-stimulated increase in DAG is derived partially from the de novo synthesis pathway. Immunoblotting studies showed increases only in PKC isoform beta II but not alpha in aortic smooth muscle cells. The phosphorylation level of MARCKS protein, an intracellular substrate of PKC, was also increased, consistent with the PKC activity increase. These findings showed that diabetic and hyperglycemia-induced increases in PKC activity and DAG levels in the heart and aorta are preventable by insulin treatment.

This article has been cited by other articles:

				Z. Liberman, B. Plotkin, T. Tennenbaum, and H. Eldar-Finkelman Coordinated phosphorylation of insulin receptor substrate-1 by glycogen synthase kinase-3 and protein kinase C{beta}II in the diabetic fat tissue Am J Physiol Endocrinol Metab, June 1, 2008; 294(6): E1169 - E1177. [Abstract] [Full Text] [PDF]

				K. Nobe, T. Yamazaki, T. Kumai, M. Okazaki, S. Iwai, T. Hashimoto, S. Kobayashi, K. Oguchi, and K. Honda Alterations of Glucose-Dependent and -Independent Bladder Smooth Muscle Contraction in Spontaneously Hypertensive and Hyperlipidemic Rat J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 631 - 642. [Abstract] [Full Text] [PDF]

				M. Campbell, W. E. Allen, J. A. Silversides, and E. R. Trimble Glucose-Induced Phosphatidylinositol 3-Kinase and Mitogen-Activated Protein Kinase-Dependent Upregulation of the Platelet-Derived Growth Factor-{beta} Receptor Potentiates Vascular Smooth Muscle Cell Chemotaxis Diabetes, February 1, 2003; 52(2): 519 - 526. [Abstract] [Full Text] [PDF]

				Y. Ido, D. Carling, and N. Ruderman Hyperglycemia-Induced Apoptosis in Human Umbilical Vein Endothelial Cells: Inhibition by the AMP-Activated Protein Kinase Activation Diabetes, January 1, 2002; 51(1): 159 - 167. [Abstract] [Full Text] [PDF]

				P. A. Watson, A. Nesterova, C. F. Burant, D. J. Klemm, and J. E.-B. Reusch Diabetes-related Changes in cAMP Response Element-binding Protein Content Enhance Smooth Muscle Cell Proliferation and Migration J. Biol. Chem., November 30, 2001; 276(49): 46142 - 46150. [Abstract] [Full Text] [PDF]

				A. M. Schmidt, S. D. Yan, J.-L. Wautier, and D. Stern Activation of Receptor for Advanced Glycation End Products : A Mechanism for Chronic Vascular Dysfunction in Diabetic Vasculopathy and Atherosclerosis Circ. Res., March 19, 1999; 84(5): 489 - 497. [Abstract] [Full Text] [PDF]

				A. W. Jones, L. Magliola, C. B. Waters, and L. J. Rubin Endothelin-1 activates phospholipases and channels at similar concentrations in porcine coronary arteries Am J Physiol Cell Physiol, June 1, 1998; 274(6): C1583 - C1591. [Abstract] [Full Text] [PDF]

				A. Malhotra, D. Reich, D. Reich, A. Nakouzi, V. Sanghi, D. L. Geenen, and P. M. Buttrick Experimental Diabetes Is Associated With Functional Activation of Protein Kinase C{epsilon} and Phosphorylation of Troponin I in the Heart, Which Are Prevented by Angiotensin II Receptor Blockade Circ. Res., December 19, 1997; 81(6): 1027 - 1033. [Abstract] [Full Text]

				J. Ren, G. A. Gintant, R. E. Miller, and A. J. Davidoff High extracellular glucose impairs cardiac E-C coupling in a glycosylation-dependent manner Am J Physiol Heart Circ Physiol, December 1, 1997; 273(6): H2876 - H2883. [Abstract] [Full Text] [PDF]

				J. R. Sowers and M. Epstein Diabetes Mellitus and Associated Hypertension, Vascular Disease, and Nephropathy : An Update Hypertension, December 1, 1995; 26(6): 869 - 879. [Abstract] [Full Text]